[ad_1]
China is also expected to announce the efficacy and safety of its national vaccine next week and begin large-scale vaccination.
Before the announcement, China had already administered “emergency vaccines” to approximately 1 million people and had even exported them to South America and Asia.
We will contact the Beijing correspondent to receive this news. Correspondent Sungwoong Kang!
About 1 million people have been vaccinated in China. Is it officially approved for use?
[기자]Vaccines that have not been developed are given priority through the “emergency use” permit.
In July, China approved the emergency use of the COVID-19 vaccine developed by the state pharmaceutical company Sinopharm.
It is mainly for medical personnel, airport quarantine officers, and overseas business travelers.
If you volunteer, you may be right.
Not long ago, the New York Times reported that there were a lot of volunteers, so we had to wait a long time to get vaccinated, and even a scalpel merchant showed up selling vaccination reserve tickets.
Sinoparm recently said that 600,000 people have been vaccinated, but about 1 million people have been vaccinated, according to Chinese media reports.
[앵커]I am curious about the safety of vaccines in China, what is it like?
[기자]Chinese drug companies and experts have repeatedly stated that there have been no serious side effects yet.
There are some things like vomiting or dizziness but it is a minor symptom and most of them heal quickly.
However, the Chinese authorities have not made any specific announcements about the effects or side effects of the domestic vaccine.
In some outlets, business travelers abroad have been affected and there have been reports that 100% immunity was effective, but it is difficult to see this as official data.
As for the effect, like Pfizer and Modena, I have to officially announce a percentage, but have not done so yet.
It is not an exaggeration to say that the entire country has also started developing vaccines in China, but that is why there are still doubts about their reliability.
[앵커]Indonesia and Brazil seriously imported vaccines from China. How did these countries make this decision?
[기자]China has been conducting vaccine clinical trials in more than 10 countries around the world, including Pakistan and Turkey, as well as Indonesia and Brazil.
In China, there are only about 10 corona19 patients a day, so clinical trials are difficult to conduct, so we have no choice but to go abroad to develop them.
In the process, Indonesia imported 1.2 million lots yesterday and Sao Paulo, Brazil, also imported 1 million lots last week.
Both countries plan to receive large-scale vaccination starting in January next year with approval for emergency use by their health authorities.
Indonesia plans to import 15 million batches by the end of this month and another 30 million in January next year, the Chinese media’s Global Times newspaper reported.
It is a method of selling the raw material of the vaccine and producing it locally.
In Brazil, the state of Sao Paulo plans to vaccinate imported vaccines from China with emergency approval in January.
But Brazil is fighting because the federal government is against it for security reasons.
[앵커]Anyway, aren’t developing countries heavily reliant on Chinese vaccines?
[기자]So is.
Turkey also said that the health minister signed a contract to buy 50 million doses of vaccines made in China’s Sinovac.
Chinese media reported that now more than 100 countries have received orders to import vaccines made in China.
There are currently six types of vaccines in the final stage of testing in China, with the main focus being the so-called “inactivated” vaccine.
Developing inactivated vaccines is an old traditional method, and the vaccine can be stored in 2-8 degree images.
Compared to Pfizer, modders and vaccines, which require cryogenic storage, the Chinese media claims that they are easy to transport and store and cheaper.
Therefore, they are showing confidence that there will be a high demand for Chinese vaccines in the developing countries of the South, Asia and Africa.
The Global Times, an observing outlet, argued that Pfizer, Moder, and vaccines can work right away, but can have long-term side effects.
[앵커]I think Chinese pharmaceutical companies should make an official announcement on safety and efficacy. When will it be published?
[기자]It is expected to be released next week.
Chinese vaccine manufacturers have already submitted data from the final phase, phase 3, clinical trials to supervisory authorities.
Reuters reported that Chinese pharmaceutical companies would make an announcement next Tuesday and Chinese media predicted that the data would be released next week.
In response to the question, ‘Why are you coming out so late in an emergency use situation?’, Professor Chang Chun-Lai from the University of Life Sciences at Jilin University in China replied, ‘It is because there are few infected people in China and data is not collected efficiently. ‘
The answer seems to be influencing the question, and while China, which has jumped into vaccine development early, is anxious that it is not making any progress.
YTN Kang Seong-woong in Beijing so far[[email protected]]it is.
